These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 17235089)
1. What have we learnt from Vioxx? Krumholz HM; Ross JS; Presler AH; Egilman DS BMJ; 2007 Jan; 334(7585):120-3. PubMed ID: 17235089 [TBL] [Abstract][Full Text] [Related]
2. Court hears how drug giant Merck tried to "neutralise" and "discredit" doctors critical of Vioxx. Moynihan R BMJ; 2009 Apr; 338():b1432. PubMed ID: 19349350 [No Abstract] [Full Text] [Related]
3. How the New England Journal missed warning signs on Vioxx: medical weekly waited years to report flaws in article that praised pain drug; Merck seen as "punching bag". Armstrong D Wall St J (East Ed); 2006 May; ():A1, A10. PubMed ID: 16848016 [No Abstract] [Full Text] [Related]
4. Open conflict on the handling of the Merck drug Vioxx by editorial giants. Edwards RG Reprod Biomed Online; 2006 Dec; 13(6):905. PubMed ID: 17169217 [No Abstract] [Full Text] [Related]
5. A message from the Vioxx case. Baldwin HJ; Droege M; Daniel KL Am J Health Syst Pharm; 2006 Mar; 63(6):503. PubMed ID: 16522877 [No Abstract] [Full Text] [Related]
7. The Vioxx pharmaceutical scandal: Peterson v Merke Sharpe & Dohme (Aust) Pty Ltd (2010) 184 FCR 1. Faunce T; Townsend R; McEwan A J Law Med; 2010 Sep; 18(1):38-49. PubMed ID: 20977160 [TBL] [Abstract][Full Text] [Related]
8. Merck's Careful Study of Vioxx. Mayer TV Am J Cardiol; 2008 Apr; 101(7):1068-9; author reply 1069. PubMed ID: 18359336 [No Abstract] [Full Text] [Related]
9. The preacher who's raising hell with Merck. Parloff R Fortune; 2005 Aug; 152(3):20. PubMed ID: 16097189 [No Abstract] [Full Text] [Related]
10. The story of Vioxx--no pain and a lot of gain: ethical concerns regarding conduct of the pharmaceutical industry. Cahana A; Mauron A J Anesth; 2006; 20(4):348-51. PubMed ID: 17072707 [No Abstract] [Full Text] [Related]
11. The Vioxx® legacy: Enduring lessons from the not so distant past. McIntyre WF; Evans G Cardiol J; 2014; 21(2):203-5. PubMed ID: 24752949 [No Abstract] [Full Text] [Related]
12. Medical journal criticizes Merck over Vioxx data. Berenson A N Y Times Web; 2005 Dec; ():A1, C13. PubMed ID: 16456990 [No Abstract] [Full Text] [Related]
13. Don't blame it all on the bogey. Day M BMJ; 2007 Jun; 334(7606):1250-1. PubMed ID: 17569929 [TBL] [Abstract][Full Text] [Related]
14. Vioxx doctors wooed by Merck are now its foes. Tesoriero HW Wall St J (East Ed); 2006 Mar; ():B1, B3. PubMed ID: 16578911 [No Abstract] [Full Text] [Related]
16. Vioxx, the implosion of Merck, and aftershocks at the FDA. Horton R Lancet; 2004 Dec 4-10; 364(9450):1995-6. PubMed ID: 15582041 [No Abstract] [Full Text] [Related]
17. Discontinuation of Vioxx. Garattini S; Bertelé V Lancet; 2005 Jan 1-7; 365(9453):24. PubMed ID: 15639671 [No Abstract] [Full Text] [Related]
18. Market withdrawal of Vioxx: is it time to rethink the use of COX-2 inhibitors? Ortiz E J Manag Care Pharm; 2004; 10(6):551-4. PubMed ID: 15548128 [TBL] [Abstract][Full Text] [Related]
19. The lessons of Vioxx. Frazier KC N Engl J Med; 2005 Sep; 353(13):1420-1; author reply 1420-1. PubMed ID: 16192497 [No Abstract] [Full Text] [Related]
20. US judge dismisses 50m dollars damages in Vioxx lawsuit. Charatan F BMJ; 2006 Sep; 333(7567):516. PubMed ID: 16960199 [No Abstract] [Full Text] [Related] [Next] [New Search]